NCT00878462View on ClinicalTrials.gov

An Acceptability Study of Unflavored Asenapine Versus Raspberry Flavored Asenapine in Stable Patients With a Psychotic Disorder (P07010)(COMPLETED)

PHASE2CompletedINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

June 29, 2005

Primary Completion Date

October 15, 2005

Study Completion Date

October 15, 2005

Conditions
Psychosis
Interventions
DRUG

Asenapine WHITE raspberry flavor (Treatment A)

Asenapine (Org 5222), 5 mg white raspberry flavored as fast dissolving tablets

DRUG

Asenapine RED raspberry flavor (Treatment B)

Asenapine (Org 5222), 5 mg red raspberry flavored as fast dissolving tablets

DRUG

Asenapine WHITE UNFLAVORED (Treatment C)

Asenapine (Org 5222), 5 mg WHITE UNflavored as fast dissolving tablets

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00878462 - An Acceptability Study of Unflavored Asenapine Versus Raspberry Flavored Asenapine in Stable Patients With a Psychotic Disorder (P07010)(COMPLETED) | Biotech Hunter | Biotech Hunter